Welcome to the world of immunohistochemistry!
📞 800-8581156 📧 info@naim.com.cn
Menu
  • Home
  • Product
  • Service and Support
    • Immunohistochemistry and Pathology
    • Immunohistochemistry Technology Exchange
    • Recommended List and Introduction of Newly Developed IHC
    • Public laboratory
    • Consultation and Feedback
  • News and Information
    • Hotspot Focus
    • Industry News
    • Maxxin Dynamics
    • Meeting Notice
  • Entering Maixin
    • Corporate Culture
    • Maisin Honors
    • Maixin Company Profile
    • Myriad Pathology Foundation Overview
  • Contact us
Close
分类
  • Consultation and Feedback
  • Hotspot Focus
  • Immunohistochemistry and Pathology
  • Immunohistochemistry Technology Exchange
  • Industry News
  • Maxxin Dynamics
  • Meeting Notice
  • News and Information
  • Public laboratory
  • Recommended List and Introduction of Newly Developed IHC
  • Service and Support
  • Uncategorized
Product Search
06 2 月
Immunohistochemistry and Pathology
Posted by author-avatar fzmaixinswy@163.com
9 2 月, 2026
0

Table 7. Prognostic Indicators for Breast Cancer

Continue reading
06 2 月
Immunohistochemistry and Pathology
Posted by author-avatar fzmaixinswy@163.com
9 2 月, 2026
0

Expression of Keratin in Normal Tissues, Cells, and Tumors

The cytoskeletal proteins in the cytoplasm of epithelial cells mainly include actin, tubulin, and cytokeratins. Cytokeratins are charac...
Continue reading
06 2 月
Immunohistochemistry and Pathology
Posted by author-avatar fzmaixinswy@163.com
9 2 月, 2026
0

Markers for Small B-Cell Lymphoma

Continue reading
06 2 月
Immunohistochemistry and Pathology
Posted by author-avatar fzmaixinswy@163.com
9 2 月, 2026
0

Immunohistochemical Markers for Multidrug Resistance in Malignant Tumors and Clinical Drug Reference (P185)

Continue reading
06 2 月
Immunohistochemistry and Pathology
Posted by author-avatar fzmaixinswy@163.com
9 2 月, 2026
0

Cytokeratin 20: Expression Rate in Epithelial Tumors

Continue reading
06 2 月
Immunohistochemistry and Pathology
Posted by author-avatar fzmaixinswy@163.com
9 2 月, 2026
0

Application of Combined Immunohistochemical Markers Cytokeratin7, Cytokeratin20, and Villin in Determining the Primary Site of Metastatic Carcinoma (1)

Continue reading
06 2 月
Immunohistochemistry and Pathology
Posted by author-avatar fzmaixinswy@163.com
9 2 月, 2026
0

Comparative Analysis of Specific Expression of Melanoma-Associated Antibodies

Melanoma-associated antigens (MAA's) can be recognized by autologous T lymphocytes, including Melan-A/MART-1, MAGE-1, MAGE-3, Tyrosinas...
Continue reading
06 2 月
Immunohistochemistry and Pathology
Posted by author-avatar fzmaixinswy@163.com
9 2 月, 2026
0

Cytokeratin Subtypes and Their Expression in Normal Cells

Continue reading
06 2 月
Immunohistochemistry and Pathology
Posted by author-avatar fzmaixinswy@163.com
9 2 月, 2026
0

Immunophenotypic Changes During B Lymphocyte Development

Continue reading
06 2 月
Immunohistochemistry and Pathology
Posted by author-avatar fzmaixinswy@163.com
9 2 月, 2026
0

Immunohistochemical Differential Diagnosis Chart for Meningioma

Continue reading
  • «
  • ‹
  • 3
  • 4
  • 5
  • 6
  • ›

Copyright © 1993 - 2017 Fuzhou Maixin Biotechnology Development Co., Ltd. MinICP No. 05015562-1 | (Fujian) - Non-commercial - 2017-0010

  • Home
  • Product
  • Service and Support
    • Immunohistochemistry and Pathology
    • Immunohistochemistry Technology Exchange
    • Recommended List and Introduction of Newly Developed IHC
    • Public laboratory
    • Consultation and Feedback
  • News and Information
    • Hotspot Focus
    • Industry News
    • Maxxin Dynamics
    • Meeting Notice
  • Entering Maixin
    • Corporate Culture
    • Maisin Honors
    • Maixin Company Profile
    • Myriad Pathology Foundation Overview
  • Contact us
Sidebar